Loading...
Implementation of Pharmacogenetics to Individualize Treatment Regimens for Children with Acute Lymphoblastic Leukemia
Despite major advances in the management and high cure rates of childhood acute lymphoblastic leukemia (ALL), patients still suffer from many drug-induced toxicities, sometimes necessitating dose reduction, or halting of cytotoxic drugs with a secondary risk of disease relapse. In addition, investig...
Na minha lista:
| Udgivet i: | Pharmgenomics Pers Med |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7429230/ https://ncbi.nlm.nih.gov/pubmed/32848445 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S239602 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|